SpringerLink
Log in

Genomics and Pharmacogenomics

  • Chapter
  • First Online:
Biotechnology for Pharmaceutical Sciences

Part of the book series: SpringerBriefs in Molecular Science ((BRIEFSMOLECULAR))

  • 45 Accesses

Abstract

Advances in knowledge of genomics and proteomics have allowed the development of new biological products. For this purpose, the articulation of research and knowledge in genomics, proteomics, and pharmacogenomics and/or pharmacogenetics is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
EUR 29.95
Price includes VAT (Germany)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR 38.51
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 53.49
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Bibliography

  1. National Human Genome Research Institute (2023) Pharmacogenomics. [consulted on 6 Dec 2023]. Available at https://www.genome.gov/

  2. CDC—Centers for Disease Control and Prevention (2023) Pharmacogenomics: what does it mean for your health? [consulted on 18 Dec 2023]. Available at https://www.cdc.gov/

  3. MedlinePlus (2022) Bethesda (MD): National Library of Medicine (US); [updated 22 Mar 2022]. MedlinePlus. Bethesda (MD): National Library of Medicine (US). What is pharmacogenomics? [consulted on 18 Dec 2023]. Available at https://medlineplus.gov/

  4. Aneesh TP, Sonal Sekhar M, Jose A, Chandran L, Zachariah SM (2009) Pharmacogenomics: the right drug to the right person. J Clin Med Res 1(4):191–194. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3299179/

  5. Pirmohamed M (2023) Pharmacogenomics: current status and future perspectives. Nat Rev Genet 24:350–362. https://doi.org/10.1038/s41576-022-00572-8

    Article  CAS  PubMed  Google Scholar 

  6. Danya K, Reem A, Ahmed W, Daly Ann K, Ingolf C, Khoueiry ZN (2023) Pharmacogenomics in practice: a review and implementation guide. Front Pharmacol 14:1663–9812. https://doi.org/10.3389/fphar.2023.1189976

  7. Bardal SK, Waechter JE, Martin DS (2011) Pharmacogenetics. Appl Pharmacol: 53–58. https://doi.org/10.1016/B978-1-4377-0310-8.00006-3

Download references

Author information

Authors and Affiliations

  1. FP-I3ID (Instituto de Investigação, Inovação e Desenvolvimento), FP-BHS (Biomedical and Health Sciences Research Unit), Faculty of Health Sciences, University Fernando Pessoa, Porto, Portugal

    Ana Catarina Silva

  2. UCIBIO, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal

    Ana Catarina Silva

Authors
  1. Ana Catarina Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Silva, A.C. (2024). Genomics and Pharmacogenomics. In: Biotechnology for Pharmaceutical Sciences. SpringerBriefs in Molecular Science. Springer, Cham. https://doi.org/10.1007/978-3-031-60061-6_9

Download citation

Publish with us

Policies and ethics

Search

Navigation